rs7827965

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_173176.3(PTK2B):​c.669+98T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.457 in 1,502,362 control chromosomes in the GnomAD database, including 159,916 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.46 ( 15972 hom., cov: 31)
Exomes 𝑓: 0.46 ( 143944 hom. )

Consequence

PTK2B
NM_173176.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.74

Publications

11 publications found
Variant links:
Genes affected
PTK2B (HGNC:9612): (protein tyrosine kinase 2 beta) This gene encodes a cytoplasmic protein tyrosine kinase which is involved in calcium-induced regulation of ion channels and activation of the map kinase signaling pathway. The encoded protein may represent an important signaling intermediate between neuropeptide-activated receptors or neurotransmitters that increase calcium flux and the downstream signals that regulate neuronal activity. The encoded protein undergoes rapid tyrosine phosphorylation and activation in response to increases in the intracellular calcium concentration, nicotinic acetylcholine receptor activation, membrane depolarization, or protein kinase C activation. This protein has been shown to bind CRK-associated substrate, nephrocystin, GTPase regulator associated with FAK, and the SH2 domain of GRB2. The encoded protein is a member of the FAK subfamily of protein tyrosine kinases but lacks significant sequence similarity to kinases from other subfamilies. Four transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.536 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PTK2BNM_173176.3 linkc.669+98T>C intron_variant Intron 7 of 30 ENST00000346049.10 NP_775268.1 Q14289-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PTK2BENST00000346049.10 linkc.669+98T>C intron_variant Intron 7 of 30 1 NM_173176.3 ENSP00000332816.6 Q14289-1

Frequencies

GnomAD3 genomes
AF:
0.456
AC:
69103
AN:
151660
Hom.:
15960
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.496
Gnomad AMI
AF:
0.628
Gnomad AMR
AF:
0.422
Gnomad ASJ
AF:
0.376
Gnomad EAS
AF:
0.254
Gnomad SAS
AF:
0.554
Gnomad FIN
AF:
0.425
Gnomad MID
AF:
0.459
Gnomad NFE
AF:
0.454
Gnomad OTH
AF:
0.439
GnomAD4 exome
AF:
0.457
AC:
617707
AN:
1350584
Hom.:
143944
AF XY:
0.460
AC XY:
310856
AN XY:
675868
show subpopulations
African (AFR)
AF:
0.489
AC:
15120
AN:
30898
American (AMR)
AF:
0.414
AC:
18069
AN:
43686
Ashkenazi Jewish (ASJ)
AF:
0.381
AC:
9478
AN:
24846
East Asian (EAS)
AF:
0.213
AC:
8292
AN:
38982
South Asian (SAS)
AF:
0.578
AC:
48164
AN:
83384
European-Finnish (FIN)
AF:
0.425
AC:
22232
AN:
52272
Middle Eastern (MID)
AF:
0.481
AC:
2597
AN:
5402
European-Non Finnish (NFE)
AF:
0.461
AC:
468040
AN:
1014488
Other (OTH)
AF:
0.454
AC:
25715
AN:
56626
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
16535
33069
49604
66138
82673
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13586
27172
40758
54344
67930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.456
AC:
69136
AN:
151778
Hom.:
15972
Cov.:
31
AF XY:
0.453
AC XY:
33600
AN XY:
74136
show subpopulations
African (AFR)
AF:
0.495
AC:
20469
AN:
41358
American (AMR)
AF:
0.422
AC:
6430
AN:
15250
Ashkenazi Jewish (ASJ)
AF:
0.376
AC:
1304
AN:
3468
East Asian (EAS)
AF:
0.254
AC:
1308
AN:
5150
South Asian (SAS)
AF:
0.554
AC:
2655
AN:
4792
European-Finnish (FIN)
AF:
0.425
AC:
4472
AN:
10534
Middle Eastern (MID)
AF:
0.459
AC:
135
AN:
294
European-Non Finnish (NFE)
AF:
0.454
AC:
30861
AN:
67922
Other (OTH)
AF:
0.443
AC:
932
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1920
3840
5761
7681
9601
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
638
1276
1914
2552
3190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.451
Hom.:
20598
Bravo
AF:
0.455
Asia WGS
AF:
0.451
AC:
1570
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.11
DANN
Benign
0.39
PhyloP100
-2.7
PromoterAI
-0.0084
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7827965; hg19: chr8-27288033; COSMIC: COSV57758158; COSMIC: COSV57758158; API